Epigenetic modifications as therapeutic targets in atheroscl…
Established
19
Citations172
Refs2023
Year
Search Works
Work Details
- DOI 10.3389/fcvm.2023.1183181
- PMID https://pubmed.ncbi.nlm.nih.gov/37304954
- OpenAlex ID W4378232378
- Type Review
- Language EN
- Published 25 May 2023
- Volume 10
- Pages 1183181
- Source Frontiers in Cardiovascular Medicine
- Publisher Frontiers Media
- FWCI 0.51
- Countries 1
- Institutions 2
- Added 26 May 2023
- Updated 27 Oct 2026
External Links
MENU
0
Epigenetic modifications as therapeutic targets in atherosclerosis: a focus on DNA methylation and non-coding RNAs
Review 2023 EN Gold
Significant progress in the diagnosis and treatment of cardiovascular disease (CVD) has been made in the past decade, yet it remains a leading cause of morbidity and mortality globally, claiming an estimated 17.9 million deaths per year. Although encompassing any condition that affects the circulatory system, including thrombotic blockage, stenosis, aneurysms, blood clots and arteriosclerosis (gen…
19
Citations
172
References
2
Authors
0.51
FWCI
Citations by Year
Last 4 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
2 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Hashum Sum | King's College London (GB) British Heart Foundation (GB) | |
| 2 | Alison C. Brewer Corresponding | King's College London (GB) British Heart Foundation (GB) |
Related Works
10Data: OpenAlex